BioAtla Files 8-K for Reg FD and Financials
Ticker: BCAB · Form: 8-K · Filed: Dec 20, 2024 · CIK: 1826892
Sentiment: neutral
Topics: disclosure, financials
TL;DR
BioAtla dropped an 8-K on Dec 20th - check it for Reg FD and financials.
AI Summary
BioAtla, Inc. filed an 8-K on December 20, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing details the company's principal executive offices located at 11085 Torreyana Road, San Diego, California, 92121.
Why It Matters
This 8-K filing serves as an official update from BioAtla, Inc. to the SEC, providing necessary disclosures and financial information to the public.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- BioAtla, Inc. (company) — Registrant
- December 20, 2024 (date) — Date of earliest event reported
- 11085 Torreyana Road (address) — Principal Executive Offices
- San Diego, California (location) — Principal Executive Offices
- 92121 (zip_code) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by BioAtla, Inc.?
The primary purpose of this 8-K filing is to report information under Regulation FD and to file financial statements and exhibits.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on December 20, 2024.
What is the exact name of the Registrant as specified in its charter?
The exact name of the Registrant is BIOATLA, INC.
Where are BioAtla, Inc.'s principal executive offices located?
BioAtla, Inc.'s principal executive offices are located at 11085 Torreyana Road, San Diego, California, 92121.
What is the telephone number for BioAtla, Inc.'s principal executive offices?
The telephone number for BioAtla, Inc.'s principal executive offices is 858 558-0708.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-12-20 08:50:36
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share BCAB Nasdaq Glo
Filing Documents
- d913994d8k.htm (8-K) — 24KB
- d913994dex991.htm (EX-99.1) — 52KB
- g913994ex99_1p1g1.jpg (GRAPHIC) — 397KB
- g913994ex99_2p10g1.jpg (GRAPHIC) — 196KB
- g913994ex99_2p11g1.jpg (GRAPHIC) — 331KB
- g913994ex99_2p12g1.jpg (GRAPHIC) — 246KB
- g913994ex99_2p13g1.jpg (GRAPHIC) — 215KB
- g913994ex99_2p14g1.jpg (GRAPHIC) — 111KB
- g913994ex99_2p15g1.jpg (GRAPHIC) — 122KB
- g913994ex99_2p16g1.jpg (GRAPHIC) — 79KB
- g913994ex99_2p17g1.jpg (GRAPHIC) — 244KB
- g913994ex99_2p18g1.jpg (GRAPHIC) — 275KB
- g913994ex99_2p19g1.jpg (GRAPHIC) — 342KB
- g913994ex99_2p20g1.jpg (GRAPHIC) — 264KB
- g913994ex99_2p21g1.jpg (GRAPHIC) — 183KB
- g913994ex99_2p22g1.jpg (GRAPHIC) — 281KB
- g913994ex99_2p23g1.jpg (GRAPHIC) — 194KB
- g913994ex99_2p24g1.jpg (GRAPHIC) — 249KB
- g913994ex99_2p25g1.jpg (GRAPHIC) — 245KB
- g913994ex99_2p26g1.jpg (GRAPHIC) — 402KB
- g913994ex99_2p27g1.jpg (GRAPHIC) — 220KB
- g913994ex99_2p28g1.jpg (GRAPHIC) — 69KB
- g913994ex99_2p29g1.jpg (GRAPHIC) — 375KB
- g913994ex99_2p2g1.jpg (GRAPHIC) — 598KB
- g913994ex99_2p30g1.jpg (GRAPHIC) — 178KB
- g913994ex99_2p31g1.jpg (GRAPHIC) — 248KB
- g913994ex99_2p32g1.jpg (GRAPHIC) — 154KB
- g913994ex99_2p33g1.jpg (GRAPHIC) — 298KB
- g913994ex99_2p34g1.jpg (GRAPHIC) — 322KB
- g913994ex99_2p35g1.jpg (GRAPHIC) — 284KB
- g913994ex99_2p36g1.jpg (GRAPHIC) — 405KB
- g913994ex99_2p37g1.jpg (GRAPHIC) — 262KB
- g913994ex99_2p38g1.jpg (GRAPHIC) — 215KB
- g913994ex99_2p39g1.jpg (GRAPHIC) — 197KB
- g913994ex99_2p3g1.jpg (GRAPHIC) — 233KB
- g913994ex99_2p40g1.jpg (GRAPHIC) — 66KB
- g913994ex99_2p41g1.jpg (GRAPHIC) — 350KB
- g913994ex99_2p42g1.jpg (GRAPHIC) — 378KB
- g913994ex99_2p43g1.jpg (GRAPHIC) — 261KB
- g913994ex99_2p44g1.jpg (GRAPHIC) — 276KB
- g913994ex99_2p45g1.jpg (GRAPHIC) — 356KB
- g913994ex99_2p46g1.jpg (GRAPHIC) — 180KB
- g913994ex99_2p47g1.jpg (GRAPHIC) — 178KB
- g913994ex99_2p48g1.jpg (GRAPHIC) — 238KB
- g913994ex99_2p49g1.jpg (GRAPHIC) — 345KB
- g913994ex99_2p4g1.jpg (GRAPHIC) — 200KB
- g913994ex99_2p5g1.jpg (GRAPHIC) — 207KB
- g913994ex99_2p6g1.jpg (GRAPHIC) — 228KB
- g913994ex99_2p7g1.jpg (GRAPHIC) — 241KB
- g913994ex99_2p8g1.jpg (GRAPHIC) — 265KB
- g913994ex99_2p9g1.jpg (GRAPHIC) — 347KB
- 0001193125-24-282547.txt ( ) — 17499KB
- bcab-20241220.xsd (EX-101.SCH) — 3KB
- bcab-20241220_lab.xml (EX-101.LAB) — 17KB
- bcab-20241220_pre.xml (EX-101.PRE) — 11KB
- d913994d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BioAtla, Inc. Date: December 20, 2024 By: /s/ Jay M. Short Name: Jay M. Short Title: Chief Executive Officer